DHR vs INTU: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Intuit Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Intuit Inc. · Technology
$267.00
+45.0% upside to fair value
Grade A
High Quality
QuantHub Verdict
INTU has more upside to fair value
(+45.0%).
INTU trades at a lower forward P/E
(16.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
INTU |
| Current Price |
$177.17 |
$267.00 |
| Fair Value Estimate |
$192.90 |
$387.15 |
| Upside to Fair Value |
+8.9%
|
+45.0%
|
| Market Cap |
$125.4B |
$73.0B |
| Forward P/E |
34.1x
|
16.1x
|
| EV / EBITDA |
20.8x
|
10.7x
|
| Price / Sales |
5.1x
|
3.5x
|
| Price / FCF |
23.7x
|
9.5x
|
| Revenue Growth YoY |
+3.7%
|
+10.4%
|
| Gross Margin |
60.7%
|
81.0%
|
| Operating Margin |
21.0%
|
27.5%
|
| Return on Equity |
7.1%
|
23.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
10.56%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Intuit Inc. is a leading technology company specializing in software applications for small businesses, consumers, and professionals, with dominant market positions in DIY tax preparation and SMB accounting. The company benefits from a durable competitive moat driven by its extensive ecosystem scale, data and AI capabilities, and strong brand recognition. Under CEO Sasan Goodarzi, Intuit has demo…
Accumulation Zones
| Metric |
DHR |
INTU |
| Zone Low |
$144.68 |
$290.36 |
| Zone High |
$163.97 |
$329.08 |
| In Buy Zone? |
No
|
Yes
|